Copolymer-1 vaccination regimens for neuroprotection in laser-induced retinal injuries

Progress in Biomedical Optics and Imaging - Proceedings of SPIE

Volumn 5688, Issue , 2005, Pages 329-336

  Belokopytov, Mark ^a   Dubinsky, Galina ^a   Belkin, Michael ^a   Epstein, Yoram ^a   Rosner, Mordechai ^a  

^a TEL AVIV UNIVERSITY   (Israel)

Author keywords

Copolymer 1; Glatiramer acetate; Immunomodulation; Laser injury; Neuroprotection; Retina; Retinal injury

Indexed keywords

CELLS; COPOLYMERS; FATTY ACIDS; IMMUNIZATION; LASER BEAM EFFECTS; LASER PULSES; OXYGEN;

GLATIRAMEL ACETATE; IMMUNOMODULATION; LASER INJURY; NEUROPROTECTION; RETINAL INJURY;

NEUROLOGY;

EID: 21844473261     PISSN: 16057422     EISSN: None     Source Type: Conference Proceeding    
DOI: 10.1117/12.583330     Document Type: Conference Paper

References (34)

1. E. Yoles, M. Schwarte, "Degeneration of spared axons following partial white matter lesion: implications for optic nerve neuropathies," Exp. Neurol. 153, 1-7, 1998.
2. D. Attwell, B, Barbour, M. Szatkowski, "Nonvesicular release of neurotransmitter," Neuron, 11, 401-407, 1993.
3. D.W. Choi, "Glutamate neurotoxicity and diseases of the nervous system," Neuron, 1, 623-634, 1988.
4. O. Dkhissi, E. Chanut, M. Wasowicz, M. Savoldelli, J. Nguyen-Legros, F. Minvielle, C. Versaux-Botteri, "Retinal TUNEL-positive cells and high glutamate levels in vitreous humor of mutant quail with a glaucoma-like disorder," Invest. Ophthalmol. Vis. Sci., 5, 990-995, 1999.
5. T. Kristian, B.K. Siesjo, "Calcium-related damage in ischemia," Life Sci. 59, 357-367. 1996.
6. A.H. Neufeld, M.R. Hernandes, M. Gonzalez, "Nitric oxide synthase in the human glaucomatous optic nerve head," Arch. Ophthalmol., 115, 497-503, 1997.
7. N.N. Osborne, G. Chidlow, J.P. Wood, K.G. Schmidt, R. Casson, J. Melena, "Expectations in the treatment of retinal diseases: neuroprotection," Curr. Eye. Res., 22, 321-332, 2001.
8. Y. Solberg, M. Rosner, J. Turetz, M. Belkin, "MK-801 has neuroprotective and antiproliferative effects in retinal laser injury,". Invest. Ophthalmol. Vis. Sci., 38, 1380-1389, 1997.
9. G. Moalem, R. Leibowitz-Amit, E. Yoles, F. Mor, I.R. Cohen, M. Schwartz, "Autoimmune T cells protect neurons from secondary degeneration after central nervous system axotomy," Nat. Med., 5, 49-55, 1999.
10. M. Kerschensteiner, E. Gallmeier, L. Behrens, V.V. Leal, T. Misgeld, W.E. Klinkert, R. Kolbeck, E. Hoppe, R.L. Oropeza-Wekerle, I. Bartke, C. Stadelmann, H. Lassmann, H. Wekerle, R. Hohlfeld, "Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation," J. Exp. Med., 189, 865-70, 1999.
11. H. Avidan, J. Kipnis, O. Butovsky, R.R. Caspi, M. Schwartz, "Vaccination with autoantigen protects against aggregated beta-amyloid and glutamate toxicity by controlling microglia: effect of CD4(+)CD25(+) T cells". Eur J Immunol., 34, 3434-3445, 2004
12. H. Schori, J. Kipnis, E. Yoles, E. WoldeMussie, G. Ruiz, L.A. Wheeler, M. Schwartz, "Vaccination for protection of retinal ganglion cells against death from glutamate cytotoxicity and ocular hypertension: Inplications for glaucoma," Proc. Natl. Acad. Sci. U.S.A., 98, 3398-3403, 2001.
13. M. Schwartz, "Neuroprotection as a treatment for glaucoma: pharmacological and immunological approaches," Eur. J. Ophthalmol., 13, S27-31, 2003.
14. M. Schwartz, "Neurodegeneration and neuroprotection in glaucoma: development of a therapeutic neuroprotective vaccine: the Friedenwald lecture," Invest. Ophthalmol. Vis. Sci., 44, 1407-1411, 2003.
15. J. Fisher, H. Levkovitch-Verbin, H. Schori, E. Yoles, O. Butovsky, J.F. Kaye, A. Ben-Nun, M. Schwartz, "Vaccination for neuroprotection in the mouse optic nerve: implications for optic neuropathies," J. Neurosci., 21, 136-142, 2001.
16. R. Barouch, M. Schwartz, "Autoreactive T cells induce neurotrophin production by immune and neural cells in injured rat optic nerve: implications for protective autoimmunity," FASEB J., 16, 1304-1306, 2002.
17. H. Schori, E. Yoles, L.A. Wheeler, T. Raveh, A. Kimchi, M. Schwartz, "Immune-related mechanisms participating in resistance and susceptibility to glutamate toxicity," Eur. J. Neurosci., 16, 557-64, 2002.
18. H. Schori, E. Yoles, M. Schwartz, "T-cell-based immunity counteracts the potential toxicity of glutamate in the central nervous system," J. Neuroimmunol., 119, 199-204, 2001.
19. M. Schwartz, "Sell Memorial Lecture. Helping the body to cure itself: immune modulation by therapeutic vaccination for spinal cord injury," J. Spinal. Cord. Med., 26, S6-S10, 2003.
20. E. Hauben, M. Schwartz, "Therapeutic vaccination for spinal cord injury: helping the body to cure itself," Trends. Pharmacol. Sci., 24, 7-12, 2003.
21. M. Schwartz, E. Hauben, "T cell-based therapeutic vaccination for spinal cord injury," Prog. Brain. Res., 137, 401-406, 2002.
22. E. Hauben, E. Agranov, A. Gothilf, U. Nevo, A. Cohen, I. Smirnov, L. Steinman, M. Schwartz, "Posttraumatic therapeutic vaccination with modified myelin self-antigen prevents complete paralysis while avoiding autoimmune disease," J. Clin. Invest., 108, 591-599, 2001.
23. J. Kipnis, T. Mizrahi, E. Hauben, I. Shaked, E. Shevach, M. Schwartz, "Neuroprotective autoimmunity: naturally occurring CD4+CD25+ regulatory T cells suppress the ability to withstand injury to the central nervous system," Proc. Natl. Acad. Sci U S A., 99, 15620-15625, 2002
24. M. Schwartz, "Protective autoimmunity as a T-cell response to central nervous system trauma: prospects for therapeutic vaccines," Prog. Neurobiol., 65, 489-496, 2001.
25. D.N. Angelov, S. Waibel, O. Guntinas-Lichius, M. Lenzen, W.F. Neiss, T.L. Tomov, E. Yoles, J. Kipnis, H. Schori, A. Reuter, A. Ludolph, M. Schwartz, "Therapeutic vaccine for acute and chronic motor neuron diseases: implications for amyotrophic lateral sclerosis," Proc. Natl. Acad. Sci. U S A., 100, 4790-4795, 2003.
26. M. Schwartz, "Autoimmunity as the body's defense mechanism against the enemy within: Development of therapeutic vaccines for neurodegenerative disorders," J. Neurovirol., 8, 480-485, 2002.
27. J. Kipnis, M. Schwartz, "Dual action of glatiramer acetate (Cop-1) in the treatment of CNS autoimmune and neurodegenerative disorders," Trends. Mol. Med., 8, 319-323, 2002.
28. M. Schwartz, "Harnessing the immune system for neuroprotection: therapeutic vaccines for acute and chronic neurodegenerative disorders," Cell. Mol. Neurobiol., 21, 617-627, 2001.
29. P.L. Prendiville, P.J. McDonnell, "Complications of laser surgery," Int. Ophthalmol. Clin., 32, 179-204, 1992.
30. Y. Barkana, M. Belkin, "Laser eye injuries," Surv. Ophthalmol., 44, 59-478, 2000.
31. H.F. Liu, G.H. Gao, D.C. Wu, G.D. Xu, L.S. Shi, J.M. Xu, H.B. Wang, "Ocular injuries from accidental laser exposure," Health. Phys., 56, 711-716, 1989.
32. M. Belokopytov, G. Dubinsky, M. Belkin, M. Rosner, "Neuroprotective vaccination with copolymer-1 decreases laser-induced retinal damage". In: Stuck BE, Belkin M, (eds.) Laser and Noncoherent Light Ocular Effects: Epidemiology, Prevention, and Treatment III. 1-6, SPIE, Bellingham, Washington, USA, 2002.
33. T. Hunig, HJ Wallny, JK Hartley, A Lawetzky, G Tiefenthaler, "A monoclonal antibody to a constant determinant of the rat T cell antigen receptor that induces T cell activation. Differential reactivity with subsets of immature and mature T lymphocytes," J. Exp. Med., 169; 73-86, 1989
34. D.L. Hirschberg, G. Moalem, J. He, F. Mor, IR Cohen, M Schwartz, "Accumulation of passively transferred primed T cells independently of their antigen specificity following central nervous system trauma," J. Neuroimmunol., 14, 88-96,1998.